Sign inGet started

Roberts Brigette

Insider CIK 1346566 · QNCX Chief Corp. Affairs Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-11362,092— $0362,092SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-116,837,319— $06,837,319SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-112,070,107— $02,070,107SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-11133,615— $0133,615SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-116,837,319— $06,837,319SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-1169,350— $069,350SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-11124,830— $0124,830SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-11228,855— $0228,855SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2026-05-182026-06-1134,675— $034,675SEC↗